WebCisplatin is a platinum containing drug first approved as an antineoplastic agent in 1978. It remains an important and effective therapy in many forms of cancer today. … WebApr 15, 2024 · Additionally, cisplatin-induced nephrotoxicity led to the unmasking of a familial form of hypomagnesemia. ... Previously, the baseline electrolyte profile was normal. He was suspected to have nephrotoxicity complicated by acute hypomagnesaemia. Hence, the boy was treated with supplementation and hypomagnesaemia recovered …
Gitelman-like syndrome after cisplatin therapy: a case report …
WebApr 19, 2024 · Cisplatin + etoposide ± doxorubicin ± mitotane Carboplatin + etoposide ± doxorubicin ± mitotane Other recommended regimens Pembrolizumab ± mitotane ... WebJan 3, 2024 · A variety of kidney diseases and electrolyte disorders can result from the drugs that are used to treat malignant disease, including conventional cytotoxic agents; molecularly targeted agents, which take advantage of molecular abnormalities that drive cancer progression; and immunotherapeutic agents. can light installation remodel
A Clinician’s Guide to Inpatient Electrolyte Replacement
WebJul 28, 2024 · Cisplatin is a platinum coordination complex chemotherapy used in the treatment of testicular, ovarian cancer, bladder, and lung cancers, as well as other … WebJun 8, 2024 · Cisplatin injection can cause dose-related peripheral neuropathy that becomes more severe with repeated courses of the drug. Neurologic symptoms … WebMay 24, 2006 · Conclusion: Cisplatin can cause permanent nephrotoxicity, including Gitelman-like syndrome. This drug should be considered among the possible causes of chronic unexplained electrolyte disorders. Publication types Case Reports Review MeSH terms Adult Alkalosis / chemically induced* Antineoplastic Agents / adverse effects* fixatives for oil pastels